Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts


About Us

Neurosurgery 2018

    On behalf of Organizing Committee we invite all the participants from all part of the world to attend the Neurosurgery conference entitled “24th International Conference on Neurology and Neurosurgery” scheduled during April 23-25, 2018 at Rome, Italy

Neurosurgery 2018 is the leading meeting dedicated to Neurosurgeons and Neurology researchers with the theme “Shed the shackles of delusions on Neurosurgery & Neurology

Goal of Neurosurgery 2018 is to deliver an outstanding program for exchange of ideas and authoritative views by leading scientists which covers the entire spectrum of research in neurological disorders and neurosurgery and share the cross-cultural experiences of various treatment procedures.

Neurosurgery 2018 is an annual meeting of Neurosurgeons as well as Neurology committees to discuss the future of the Neurosurgery and Neurological disorders in terms of collaboration, structures and organizational development and advances of Neurology and Neurosurgery.

As most of us know, according to the latest survey conducted by WHO, it is revealed that Neurological Disorders encompassing Stroke, Alzheimer & Dementia, Epilepsy and many more accounts for more than 12% of deaths worldwide on an average and it is also predicted that the number of disability –adjusted life years vanished due to Neurological disorders are expected to accelerate from 95 million globally in 2015 to 103 million by 2030.

Moreover, the worldwide cost of neurological sequela solitary estimated in 2010 was US $2.5 trillion and it is assumed that the value will spike to over US $6 trillion by 2030.

Why to attend?

     We strive to make Neurosurgery 2018 a success, with your support and high quality talks from both Neurology and Neurosurgery communities. During the conference, we assure you that you will experience world class facilities and hospitality at the conference.

24th International Conference on Neurology and Neurosurgery is a unique forum to bring together worldwide distinguished academics in the field of Neuroscience, Neurology and Neurosurgery, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. The Conference will feature many exciting academic programs including multiple panels, workshops, affinity group lunches, paper presentations, and scientific sessions by reputed neurologists and neurosurgeons from all over the country.

Neurosurgery 2018 Highlights includes:

Earn up to 21 CME Credits

CPD Credits by CPD Standards Office, UK

IOCM Certification

One on One Meeting with Eminent Speakers from 40 Countries

Live Streaming of the conference

Keynote sessions by world’s most eminent researchers at Brain Disorders research

Top Industries Representation

Thought provoking Symposia’s and Workshops

Preconference workshops in all major countries

Nominations for Best Poster Award

Outstanding Young Researcher Award

Group Registration benefits

Your attendance and participation will be greatly appreciated as we seek to strengthen the expertise in field of Neurology and Neurosurgery!!


On behalf of the Organizing Committee, it is with great pleasure that we welcome you to the official website of the 24th International Conference on Neurology and Neurosurgery during April 23-25, 2018 at Rome, Italy.

Neurosurgery 2018 has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Committee

The live format of this educational activity will be accredited with CME and CPD Credits.

Track 1:  Neurology

Neurology deals with injuries, disorders, diagnosis and treatment of the brainspine and nervous system including their coverings, blood vessels, and all effector tissues. More than 600 known neurological disorders are there which affects our nervous system severely but still for most of the diseases treatment options are very limited and research is going on. According to a global study conducted by World Health Organization 8 out of 10 disorders are neurologic problems in which 3 are highest disability classes. Every year 6.8 million people are dying all over the world due to neurological disorders or injury. In Europe 38% of total population is suffering from a brain disorder. In United States Stroke is the third leading cause of death.  Globally 62 million people are suffering from cerebrovascular disease, 50 million from epilepsy, 326 million from migraine,160 among 100000 from Parkinson’s disease and 24 million from Alzheimer disease dementias. The global cost of mental health conditions alone is $ 2.5 trillion as of now and is expected to reach $6 trillion by the year 2030.

Track 2: Neurosurgery

Neurosurgery is the surgical speciality performed on the brain, spinal cord, nervous system and extra-cranial cerebrovascular system. Paediatric Neurosurgery deals with nervous system disorders and injuries of a child. Functional Neurosurgery treats central nervous system disorders and damages by Neurostimulation, Intrathecal drug delivery, Neuroablative therapies and many other newer techniques. Global Neurosurgery Market is expected grow at 11.7% CAGR by 2019. Global Interventional Neurology Market Is expected to reach $2,370.4 Million by the year 2020, expected to have a CAGR of 8.4% from 2015 to 2020. North America holds the largest share of neurovascular devices and surgical imaging market followed by Europe and Asia Pacific due to well acceptance of advanced devices among Neurosurgeons all over the world and it was $378.6 million in 2014.

Track 3:  Cerebrovascular Surgery

Cerebrovascular disorders are conditions that are caused by problems which affect the blood supply to the brain. It is third most frequent cause of death and leading cause of adult disability.  Of the 750,000 people suffer stroke annually 170,000 will die due to stroke.

The most common forms of cerebrovascular disease are cerebral thrombosis and cerebral embolism followed by cerebral haemorrhage.

The four most common types are: Stroke, subarachnoid haemorrhage, Transient ischaemic attack and vascular dementia.

Cerebrovascular surgery involves operative treatment of neurovascular disorders of the brain and spine and surrounding blood vessels. The most common maladies treated by a cerebrovascular surgery include arteriovenous malformations, aneurysms and stroke. Globally 62 million people are suffering from cerebrovascular disease each year

Track 4: Brain Tumour

Brain tumour is an abnormal growth of central spine or brain tissue that can disrupt brain function. Brain tumor can be Benign, Malignant, Primary or Metastatic. 71% of all brain tumour deaths occur under the age of 65. According to the American Society of Clinical Oncology (ASCO) cerebrum tumor development rate is 2.6% per year in USA. As per CDC report roughly 20 instances of essential brain tumor per 100,000 individuals are found per year in USA.

Track 5: Neurological Disorders

There are more than 600 diseases of the nervous system such as brain tumors, epilepsy, Parkinson's disease, dementia and stroke.

Chronic pain is a frequent component of many neurological disorders which affects 20–40% of patients for many primary neurological disorders.

Medications, local electrical stimulation, acupuncture and brain stimulation as well as surgery are some of the treatments for chronic pain

Track 6:  Functional Neurosurgery

Epilepsy may occur as a result of a number of other conditions including tumors, strokes, head trauma, previous infections of the central nervous system, genetic abnormalities, and as a result of Brain damage around the time of birth. Parkinson’s disease is a degenerative disorder of the central nervous system mainly affecting the motor system. The motor symptoms of Parkinson’s disease result from the death of dopamine-generating cells in the substantia nigra, a region of the mid brain.

Track 7:  Traumatic Neurosurgery

Traumatic Brain Injury (TBI) is a nondegenerative, noncongenital affront to the brain from an outer mechanical power, potentially prompting perpetual or impermanent disability of psychological, physical, and psychosocial capacities with a related decreased or modified condition of cognizance. Frequently, the term brain injury is utilized synonymously with head damage, which may not be connected with neurological deficiencies. The definition additionally has been dangerous with varieties in consideration criteria. In case of diffuse axonal injury brain neurons which communicate with each other are injured and loss the ability to communicate and integrate with each other. In United States 1.4 million people endure a traumatic brain injury (TBI) each year among which around 50,000 die, 235,000 are hospitalized. Head injury is very common among young adults and Trauma is the leading cause of death in people under 40.

Track 8: Skull base Neurosurgery

Skull base surgery is an exceptionally concentrated arrangement of surgical strategies performed to treat different conditions that influence the skull. Skull base surgery is done to remove both benign and cancerous tumours, abnormalities of brain and few vertebrae of the spinal column. Skull base surgery is performed either traditional way or by minimally invasive way. Brain damage consists 35% of total injuries all over the world. Cost burden is €400 billion every year in Europe.

Track 9: Spinal Surgery

Vertebral column or spine is a part of axial skeleton consisting 33 bones. There is a number of disorders and injuries which effects our sentation, body control and movement severely. For some spinal disorders, surgery is not required but for severe cases surgery is essential. Minimally invasive spine surgery treats Degenerative disc disease, Lumbar spinal stenosis, Spinal deformities, Spinal Tumors, Spinal infections and many other conditions.

Spinal fusion market is expected to reach $6.9 billion by 2020. Global spinal surgery devices market is expected to reach $14.8 billion by 2017, with an estimated yearly growth rate of 5.1% in the next five years and in Europe it is expected to reach $2,993.6 million by 2019.

Track 10:  Endovascular Neurosurgery

Endovascular neurosurgery or neuro-interventional surgery is a procedure in which small tools are used which passes through blood vessels to diagnose and treat various disorders and conditions of the central nervous system. The term endovascular means “inside a blood vessel.” Endovascular neurosurgery uses tools that pass through the blood vessels to diagnose and treat diseases and conditions rather than using open surgery. The surgeon often uses radiology images to help him or her to see the part of the body involved in the procedure. This minimally invasive image guide technique is well accepted over traditional surgery as it minimizes the risks and provides healthy outcomes and quick recovery. Angiography devices market is expected to reach $27.7 billion by 2019. Global Interventional Neurology Market Is expected to reach $2,370.4 Million by the year 2020.

Track 11:  Neurosurgery and Nursing

Neurological Nursing is a nursing specialty dealing with assessment, nursing diagnosis and management of brain and nervous system disorders, tumors, brain injuries, trauma, spine injuriesstroke, seizures aneurysms and many more conditions.

Critical illness defines severe damage of vital organs like Central nervous system failure, brain damagespine injury and there is a chance of life threatening deterioration in the patient’s condition. Critical care is time dependent and delivered by physician to a critically injured patient and requires high complex decision to assess, monitor, manipulate and support vital organ function in order to treat vital organ system failure.

Track 12:  Neuroanaesthesia and Critical Care

Neuroethics or ethics of neuroscience deals with social, legal, ethical and policy implications of advances in neuroscience. It is an interdisciplinary research area that focuses on ethical issues raised by increased and constantly refining understanding of brainspine and nervous system. It also deals with concomitant understanding of the biological bases of agency and ethical decision-making.

Track 13: Novel Therapeutics

The goal of this session is to understand the Novel Treatment strategies like Therapeutic Brain stimulation (electric and magnetic), Tau-Based Treatment Strategies in Neurodegenerative Diseases, Anti-amyloid therapy, Comprehensive treatment, Therapeutic dilemmas in multiple sclerosis and Future research directions in Brain disorders.

Track 14:  Advance Techniques on Neurosurgery

Diagnostic tests and procedures are vital tools that help physicians confirm or rule out the presence of a neurological disorder or other medical condition. Tests and techniques such as Chorionic villus sampling, Pre-symptomatic testing, Biomarkers, Molecular diagnostics, Neuroimaging and Human Neuroimaging are commonly used to diagnose. Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. This is in contrast to classical synaptic transmission, in which one presynaptic neuron directly influences a single postsynaptic partner. Neuromodulation can be conceptualized as a neurotransmitter that is not reabsorbed by the pre-synaptic neuron or separated into a metabolite. Such neuromodulators wind up investing a lot of energy in the cerebrospinal liquid (CSF), affecting (or "regulating") the action of a few different neurons in the cerebrum. Consequently, a few neurotransmitters are likewise thought to be neuromodulators, for example, serotonin and acetylcholine. Worldwide neuromodulation business market was evaluated at $3.65 Billion in 2015 and estimated to reach $6.20 Billion by 2020 with a CAGR of 11.2%.

Track 15:  Case reports in Neurosurgery

More than 1 billion people are suffering from neurological disorders and every year around 6.8 million people are dying due to various neurological disorders and injury. More than 600 known neurological disorders are there which affects our nervous system severely but still for most of the diseases treatment options are very limited and research is going on. Case reports on Neurosurgery track is designed to share scientists, researchers, doctor’s practical experience of new and critical neurological conditions and injuries and to influence young researchers. It will give researchers knowledge and ideas about new technologies, clinical trials, drug testing and other new aspects.


Market Analysis

Neurosurgery and Neurology Market Analysis

Neurosurgery conference focuses on broad array of disorders and cure of spine, brain and connecting neurons. Neurological disorders are one of the greatest threats to public health.

According to the latest survey conducted by WHO, it is revealed that Neurological Disorders encompassing Stroke, Alzheimer & Dementia, Epilepsy and many more accounts for more than 12% of deaths worldwide on an average and it is also predicted that the number of disability –adjusted life years vanished due to Neurological disorders are expected to accelerate from 95 million globally in 2015 to 103 million by 2030.

Moreover, the worldwide cost of neurological sequelae solitary estimated in 2010 was US$ 2.5 trillion and it is assumed that the value will spike to over US$ 6 trillion by 2030.

Glancing at Europe, the cost of Neurological diseases was reputed to be Euro798 billion whereas in America it was estimated more than $ 760 billion per year. Altogether these values make clear about the contribution of Neurological disorders and diseases towards global burden and pinpoint the potentially boundless demand of Neuroscience Research.

The above discussion highlights that an ample of resources is needed to recover the people suffering from Neurological Disorders and Diseases. It can also be assumed that the analyses such as above will be endorsed as a crucial element of decision making & will be accustomed to major planning actions at national & regional levels, global, so as to utilise the accessible resources more dexterously.

The recent survey had shown that researchers in Italy received overall grant of €23.5 million from European Research Council (ERC). Italy ranked second by securing 31 projects amongst the rest of the European countries. Nevertheless under 7th Work Program by ERC, France received a grant of €7.5billion including 3 domains amongst which Life science domain alone received funding of €2.9 billion. The impact of getting raised funding directly points towards the increase in number of life science researchers from the past five years.

The European Brain Council estimated that in 2010 in Europe alone cost of neurological diseases one trillion dollars a year.

Worldwide Market always characterised by acute competition on ground of burgeoning number of firms & pervasive R & D. Emerging markets with the establishments of novel technologies in the arena of neuroscience are boosting finest revenues which further led to the growth of this market over the forecast span.

Neurosurgery is a surgical speciality concerned with diagnosis, prevention, treatment and cure of various neurological disorders and injury of brain, spine and nervous system. North America holds the largest neurosurgery market followed by Europe. From 2014 to 2019, Global Neurosurgery market is expected to grow at a CAGR of 11.71%.

Around 1000 clinical neurologist and neurosurgeons are working exclusively on Neurology and Neurosurgery in Paris.

There are about 6 million people in Paris living with a neurological condition which has a significant impact on their lives.

Past Conference report

Past Conference Report:

13th International Conference on Neurology and Neurosurgery was organized during June 19-21, 2017 at Novotel MARNE LA VALLÉE - Noisy le Grand, Paris, France with great support and contribution by our honorable Organiz­ing Committee Members.

Firstly, we must thank you for trusting us and participating at Neurosurgery 2017, a global platform to dis­cuss various important aspects of Neurology and neurosurgery.

There are infinite reasons to extend our gratitude to you for making Neurosurgery 2017 an outstanding con­ference. We couldn’t have done it without your continuous support and believe towards our organization, which mutually made to achieve Neurosurgery 2017 a new heights in the field of Neuroscience.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 15 countries, who have driven this event into the path of success.

The conference was organized around the theme “Shed the shackles of delusions on Neurosurgery & Neurology”. The event implanted a firm relation of upcoming strategies in the field of Novel approaches and Developments in Neurosurgery with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture sci­entific accelerations.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:

Roberto Cartolari, S. Giovanni Hospital, Switzerland

Xiaoping Ren, Harbin Medical University, China

Guy Hugues Fontaine, Université Pierre et Marie Curie, France

Radu Mutihac, University of Bucharest, Romania

Walter Bini, Healthpoint Hospital, UAE

Hugues Duffau, Gui de Chauliac Hospital, France

Special sessions:

                Radu Mutihac from University of Bucharest, Romania delivered special session on “Brain connectivity dynamics in neurological dysfunctions”

                Vera Novak, Harvard Medical School, USA presented on “Brain signatures of metabolic syndrome and new treatment options for cognitive decline”


                Workshop presentation on  the theme of Regenerative Medicine: options for the treatment of degenerated spinal discs by Walter Bini, Healthpoint Hospital, UAE, Karin Wuertz-Kozak, ETH Zurich, Switzerland and Katy Moncivais, Celling Biosciences, USA

The conference witnessed an amalgamation of peerless speakers, Keynote sessions, workshops, symposium well-known re­searchers and delegates who enlightened the crowd with their enviable research knowledge and on vari­ous alluring topics related to the field of Neurology and Neurosurgery through their fabulous pre­sentations at the podium of Neurosurgery 2017. So as a continuation of Neurosurgery 2017, we would like to heartily invite you to our upcoming 24th International Conference on Neurology and Neurosurgery during April 23-25, 2018 at Rome, Italy.

For Neurosurgery 2018 we are expanding our focus towards all aspects of Neurosurgery Research findings. Our organizing committee is gearing up with more innovative and explorative sessions to unleash the boundaries of the Neurology and Neurosurgery.

Your expertise and knowledge in the area of Neurology and Neurosurgery will provide an opportunity to discuss and respond to a series of questions about the status of advancement of Neuroscience

Past Conference Report

Supported By

Journal of Neurology & Neurophysiology Journal of Neurology and Neuroscience Journal of Spine & Neurosurgery Journal of Spine

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by